plant phenolics drug leads missing pubmed ncbi abstract low molecular weight phenols plant origin undoubtedly semiochemicals easily classified typical allelochemicals straightforwardly benefit releaser selected surveyed class secondary metabolites shares high chemical reactivity intrinsic biocompatibility affinity variety molecular targets gained evolution suitability prospective lead compounds medicinal chemistry high unexplored plant phenolics perceived natural product library privileged scaffolds evidenced examples endogenous phenols phytochemicals aryl hydroxyl groups phenolic synthetic drugs postulated application bio-chemo-informatic tools library helpful pulling drug candidates validating admet compatibility suitability short survey structural diversity represented plant phenolics focus compounds obvious dietary significance rich record pharmacological studies growing phytochemicals dietary supplements slow progress clinical trials drug registration observed category natural products waste resources transformation renewable materials high tech/high products aimed improved human healthcare deplorable reformed sustainability attempt answer question popular plant phenolics established health benefits recognized molecular pharmacology catechins curcumin resveratrol quercetin glycosides genistein silymarin difficulties attaining registered drug ind level 
